QT IMAGING HOLDINGS, INC.
No enriched coverage for $QTI in the last 7 days.
No SEC Form 4 filings for $QTI in the last 30 days.
See all $QTI insider activity →QT Imaging Holdings (QTI) announced that its Breast Acoustic CT scanner is now available through a national group purchasing agreement with Premier, facilitated by distributor NXC Imaging. This agreement offers eligible Premier members pre-negotiated pricing and terms, potentially expanding QTI's market reach.
QT Imaging (QTI) announced that CPT code 1079T for its 3D breast acoustic imaging became effective Oct. 1, 2026, three months earlier than expected. This allows the company to begin implementation work with providers and payers sooner, supporting its commercialization efforts.
QT IMAGING HOLDINGS, INC. (QTI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Chief Executive Officer Restricted Stock Unit Grant On August 28, 2026, the Board of Directors (the “ Board ”) of QT Imaging Holdings, Inc. (the “ Company ”), upon the recommendation of the Compensation Committee of the Board, approved a grant to Dr. Dinu, under the Com
Recent QTI coverage spans financial news, corporate actions and earnings.
The agreement opens a distribution channel into major health systems, suggesting future revenue upside.
Earlier reimbursement code may accelerate revenue generation and boost share price.
Compensation grant is a routine corporate action with limited immediate price impact.
The call provides fresh, decision-relevant datapoints: revenue/guidance, shipment cadence, and financing terms that affect near-term risk and valuation.
The 8-K adds fresh, decision-relevant fundamentals: stronger-than-prior-year revenue momentum, capital raise to fund scale, and reaffirmed full-year guidance alongside regulatory and manufacturing progress.
AlphAI scores every news story that mentions QTI with an AI model for sentiment and relevance, and aggregates insider trades from QT IMAGING HOLDINGS, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
QT Imaging Holdings (QTI) announced that its Breast Acoustic CT scanner is now available through a national group purchasing agreement with Premier, facilitated by distributor NXC Imaging. This agreement offers eligible Premier members pre-negotiated pricing and terms, potentially expanding QTI's market reach.
1 min readQT Imaging (QTI) announced that CPT code 1079T for its 3D breast acoustic imaging became effective Oct. 1, 2026, three months earlier than expected. This allows the company to begin implementation work with providers and payers sooner, supporting its commercialization efforts.
1 min readQT IMAGING HOLDINGS, INC. (QTI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Chief Executive Officer Restricted Stock Unit Grant On August 28, 2026, the Board of Directors (the “ Board ”) of QT Imaging Holdings, Inc. (the “ Company ”), upon the recommendation of the Compensation Committee of the Board, approved a grant to Dr. Dinu, under the Com
1 min readQT Imaging Holdings (QTI) reported Q2 2026 revenue of $7.4 million, up 103% year over year, driven by 15 scanner shipments. First-half revenue was $14 million. Fiscal 2026 guidance calls for about $39 million revenue. Q2 gross margin was 41%; operating loss $1.9 million and net loss $11.1 million. Company extended debt to 2029 and raised $10 million via an offering.
7 min readQT IMAGING HOLDINGS, INC. (QTI) filed an SEC Form 8-K — Results of Operations and Financial Condition. QT Imaging Delivers Strong Second Quarter Growth While Building the Foundation for Commercial Scale Second-quarter revenue reached $7.4 million; first-half revenue increased 116% to $14.0 million, with 28 scanners shipped Strengthened capital position through a $10.0 million publ
6 min readQT IMAGING HOLDINGS, INC. (QTI) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. qti-20260728 false 0001844505 3 Hamilton Landing Suite 160 Novato CA 94949 415 842-7250 QTI 0001844505 2026-07-28 2026-07-28 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________ FORM 8-K ________________________________
2 min readQT Imaging Holdings, Inc. announced its financial results for the fourth quarter and full year ended December 31, 2025, reporting record full-year revenue of $18.9 million, exceeding guidance, and shipping 40 scanners. The company affirmed its 2026 revenue guidance of approximately $39 million, driven by distributor partnerships and the QTI Cloud Platform. Key achievements include FDA clearance for an updated scanner configuration, approval of a new Category III CPT code for its Breast Acoustic CT, and significant financial strengthening through a private placement.
4 min readQT Imaging Holdings, Inc. announced the first commercial sale of its QTI Breast Acoustic CT™ System to True Health Center for Functional Medicine, following a strategic distribution partnership. This innovative system aims to improve breast imaging by eliminating compression, radiation, and the need for contrast agents, focusing on patient comfort and safety. The technology, validated by the National Institutes of Health, provides high-quality 3D images and addresses limitations of traditional methods, especially for dense breast tissue.
3 min readQT Imaging Holdings (QTI) has released a new investor presentation detailing supplemental product and operational information, including its FDA-cleared QT Breast Scanner. The presentation aims to manage investor expectations by providing regulatory context, financial metrics, and extensive risk disclosures. Spark, TipRanks' AI Analyst, rates QTI as "Neutral" due to weak financial performance tempered by recent positive corporate updates.
2 min readQT Imaging Holdings, Inc. (QTIH) has announced a partnership with Olea Medical to integrate advanced visualization, quantitative analytics, and AI-ready imaging capabilities into QT Imaging's cloud-based SaaS platform. This collaboration aims to enhance clinical interpretation, support research workflows, and enable advanced quantitative imaging analysis, particularly in breast imaging. The integration is expected to strengthen QT Imaging's position by offering a comprehensive, cloud-based platform that combines its acoustic imaging technology with established radiology tools and analytics.
3 min read
